The top ten quality and performance measures to prevent sudden cardiac death can help healthcare professionals and family members to provide care for those at high risk.
- Sudden cardiac death is an unexpected loss of heart function.
- Ten performance and quality measures for the prevention of sudden cardiac death have been released in a new report.
- These measures can assist clinicians to use guideline-directed medical therapy for prevention of sudden cardiac death in patients with heart attack.
The ten performance measure are intended to assist clinicians in providing better care for their patients who are at risk of sudden cardiac death. The performance measures can also help improve care and patient outcome.
"This is the first comprehensive measure set in the area of sudden cardiac death prevention. Our vision is that these measures will be developed, tested, and implemented in clinical practice and that implementation will improve patient care and outcomes," said Sana Al-Khatib, MD, FACC, co-chair of the writing committee and professor of medicine at Duke University.
"While some people--such as patients with heart failure--are known to be at risk of sudden cardiac death, others are not. We need initiatives to improve the quality of care for those with a known risk, but also for the victims of sudden cardiac arrest," Al-Khatib said.
Performance and Quality Measures for the Prevention of Sudden Cardiac Death
- Smoking cessation intervention in patients who suffered sudden cardiac arrest, have a life-threatening ventricular arrhythmia or are at risk for sudden cardiac death
- Screening for family history of sudden cardiac death
- Screening for asymptomatic left ventricular dysfunction among individuals who have a strong family history of cardiomyopathy and sudden cardiac death
- Referring for cardiopulmonary resuscitation (CPR) and automated external defibrillator (AED) education to those family members of patients who are hospitalized with known heart conditions that increase the risk of sudden cardiac arrest
- Use of implantable cardioverter defibrillators (ICDs) for prevention of sudden cardiac death in patients with heart failure and reduced ejection fraction who have an anticipated survival of more than one year
- Use of guideline-directed medical therapy for prevention of sudden cardiac death in patients with heart failure and reduced ejection fraction
- Documenting the absence of reversible causes of ventricular tachycardia/ventricular fibrillation cardiac arrest and sustained ventricular tachycardia before a secondary prevention ICD is placed
- Counseling eligible patients about an ICD
- Counseling first-degree relatives of survivors of sudden cardiac arrest associated with an inheritable condition about the need for screening for the inheritable condition
Sudden cardiac death occurs due to Hypertrophic cardiomyopathy (HCM) (the heart muscle becomes abnormally thick), Coronary artery abnormalities, and Long QT syndrome (inherited heart rhythm disorder).
Facts
In the United States, nearly 356,500 out-of-hospital cardiac arrests occur each year. Most of the sudden cardiac deaths can be prevented by implementing evidence-based and guideline-endorsed recommendations for primary or secondary prevention of sudden cardiac death. But sudden cardiac death can occur in people who do not appear to be at high risk.
Reference:
- Sana M. Al-Khatib, Clyde W. Yancy, Penelope Solis, Lance Becker, Emelia J. Benjamin, Roger G. Carrillo, Justin A. Ezekowitz, Gregg C. Fonarow, Bharat K. Kantharia, Monica Kleinman. Clinical Performance and Quality Measures for Prevention of Sudden Cardiac Death : A Report of the American College of Cardiology/American Heart Association Task Force on Performance Measures. Journal of the American College of Cardiology,(2016) DOI: 10.1016/j.jacc.2016.09.933
Source-Medindia